Related by context. All words. (Click for frequent words.) 61 PROactive PROspective Clinical Trial 60 Reduce Cardiovascular 59 Aranesp Therapy 58 Major Adverse Cardiac 57 OLYMPIA registry 55 DIARY Federal Reserve 54 Onyx Pharmaceuticals Announces 54 ID NCT# 53 Val HeFT 53 Upcoming BIO 53 Phase IIb III 52 Bayer HealthCare Onyx Pharmaceuticals 52 CARE HF 52 Optical Coherence Tomography 52 Prostate AdenoCarcinoma Treatment 52 Phase Ib Clinical Trial 52 randomized blinded 52 Randomized controlled 52 XL# XL# XL# 52 APEX AMI trial 52 Prospective Multicenter 52 Phase III AFFIRM 52 STRIDE PD 52 prospective multicentre 52 Multidetector CT 51 IMPACT IMmunotherapy 51 PROactive study 51 Aortic Dissection 51 p# biomarker 51 Phase 2b RESTORE CLI 51 STRATEGY FOR AN OPEN 51 placebo controlled Phase III 51 MEND CABG 51 ThermoDox ® clinical 51 prospective multicenter study 51 Carotid Revascularization Endarterectomy vs. 51 MelaFind pivotal 51 Histopathologic 51 Ovarian PLCO Cancer 50 Clinical Antipsychotic Trials 50 Intervention Effectiveness 50 registrational Phase 50 relapsed MCL 50 LUMINATE 50 optical coherence tomography 50 EINSTEIN DVT 50 BRIM2 50 Intra operative 50 preclinical efficacy 50 WHIMS 50 Phase 1a clinical 50 Phase Ib II 50 atherosclerotic cardiovascular 50 BRIM3 50 ExTRACT TIMI 50 Tomographic 50 Pharmacodynamic 50 pivotal bioequivalence 50 number NCT# ClinicalTrials.gov 50 Initiated Phase 50 Prostate Disease 50 Matrix Phase 2b 50 longitudinal cohort study 50 DA VINCI 50 Combination REOLYSIN R 50 pharmacokinetic PK 50 Podium Presentation 50 randomized controlled multicenter 50 Virtual Histology 50 prospective observational 50 Endoscopic ultrasound 50 Investigator Initiated 50 VITAL Trial 50 multicentre prospective 49 CaPSURE 49 optical coherence tomography OCT 49 CABANA 49 AVOREN 49 Guanilib 49 observational cohort study 49 Endovascular System 49 Computed tomographic 49 NCIC CTG 49 Airborne Geophysical 49 Randomized Evaluation 49 neratinib 49 multicenter multinational 49 ONTARGET 49 Magnetic resonance 49 Cardiac Allograft Rejection 49 florbetaben 49 Optical coherence tomography 49 Mammographic 49 Observational Study 49 Acute Decompensated Heart Failure 49 Thrombolysis 49 BCIRG 49 FDG-PET/CT 49 geochemical geophysical 48 Echocardiographic 48 Natural Orifice Surgery 48 SPECT Single Photon 48 STUDY RESULTS 48 Heart Transplant Recipients 48 multicentric 48 PD2i 48 ACUITY trial 48 Phase #/#a trial 48 PINPOINT 48 SPIRIT FIRST 48 EchoCRT 48 substudy 48 geochemistry geophysics 48 RADIANT 48 Syllego system 48 Coronary Artery Calcium 48 PROTECT AF 48 prospective longitudinal 48 PreCISe 48 Asthma Intervention 48 Aeolus Pharmaceuticals Announces 48 Upcoming Milestones 48 Cardioxyl Pharmaceuticals 48 Multicenter Phase 48 Ida Dome 48 Sibutramine Cardiovascular Outcomes 48 ENDEAVOR IV 48 RECORD1 48 geophysical geochemical 48 Carotid 48 Phase Ib clinical 48 BARI 2D 48 PCI ExTRACT TIMI 48 PERSEUS 48 Brucejack Area 48 molecular biomarker 48 blinded randomized placebo controlled 48 NSABP B 48 lorcaserin Phase 48 TAXUS ATLAS 48 cytoreductive nephrectomy 48 randomized discontinuation 48 Patient Outcomes 48 STEALTH C 48 STENT 48 Dr. Kandzari 48 multidetector row 48 Prostate Lung Colorectal 48 Histologic 48 initiated Phase 1b 48 PFO migraine 48 KIF6 carriers 48 Capsule endoscopy 47 anomalous geochemical 47 Ischemic 47 QTinno TM 47 prospective multicenter 47 NSABP 47 Lp PLA 2 47 IMAGING 47 Intervention Trial GAIT 47 TRANSFORMS 47 phase Ib 47 #nd EORTC NCI 47 corneal topography 47 Landsat imagery 47 Niris 47 Imaging BSGI 47 varespladib 47 LightLab OCT 47 Histological 47 Active Ulcerative Colitis 47 coronary computed tomography 47 microarray gene expression 47 deterministic nonlinear measure 47 phase IIb study 47 Prostate Cancer Outcomes 47 SCD HeFT 47 ASSERT 47 tissue microarrays 47 Topline Results 47 Mobile Metal Ions 47 CHAMPION PCI 47 RE LY ® 47 Clinical Trial Results 47 preclinical pharmacokinetic 47 SiMoA 47 Confirmatory 47 IP Resistivity 47 PHASE III 47 International Verapamil SR 47 IMPACT DCM 47 Nasdaq PCYC 47 electrocardiography ECG 47 Ovarian Cancer Screening 47 RE LY 47 nonrandomized 47 BUSINESS CALENDAR 47 Acute Coronary Syndromes ACS 47 vitro ADME 47 Market Realities Implementation 47 REALITY Trial 47 Patient Registries 47 NuroPro PD 47 Trandolapril 47 TransVax ™ 47 RADIANCE 47 Telik Announces 47 geologic geochemical 47 retrospective cohort study 47 Digital Mammographic Imaging 47 TG MV 47 www.inter citic.com 47 PD2i ® 47 Myocardial Infarction 46 Industry Announcements 46 Optical Coherence Tomography OCT 46 OBJECTIVES 46 prospectively defined 46 Enzyme Leach 46 Tomography SPECT 46 prospective observational studies 46 AIM HIGH 46 DecisionSpace Desktop 46 Phase IIIB IV 46 phase IIa clinical 46 Cardiac CT 46 Microdosing 46 acadesine 46 x ray computed tomography 46 YONDELIS 46 randomized Phase 2b 46 Phase III Psoriasis 46 TRA 2P 46 haplotype map 46 DRILL RESULTS 46 observational cohort 46 ACRIN 46 Long Lesion 46 Annoucement 46 C7 XR 46 novel VDA molecule 46 Meta analyzes 46 myocardial viability 46 MBIR 46 atherothrombotic disease 46 Phase IIB 46 VADT 46 EURIDIS 46 TAXUS V 46 FD OCT 46 AVADO 46 pharmacodynamic PD 46 abstr 46 Single Photon Emission Computed 46 Tomophase 46 Ancrod 46 GetGoal Phase III 46 ATTR CM 46 Positive Scoping Study 46 CAMMS# 46 META Group Nasdaq METG 46 noninvasive imaging 46 ORAL Solo 46 MADIT 46 DEV DA TOMAR NEXT 46 OLAP analysis 46 mg/m2 cohort 46 Exelixis XL# 46 Phase 2b monotherapy 46 National Oncologic PET 46 meta regression 46 Computed Tomographic 46 ongoing Phase 1b 46 crizotinib PF # 46 PD2i R 46 Thorough QT 46 pigmented skin lesions 46 Phase III ALLEGRO 46 Multi Ethnic Study 46 placebo controlled clinical 46 pharmacokinetics PK 46 ZFP Therapeutics 46 ANCHOR trial 46 USA UroToday.com 46 PRELUDE 46 Phase 2b Study 46 ICON7 46 Gradient Array 46 Intervention Effectiveness CATIE 46 bevirimat Study 46 patientswith 46 Induced polarization 46 serious cardiovascular thrombotic 46 CHARISMA trial 46 CAPRIE 46 #:#,# scale [002] 46 CATIE AD 46 Cardio3KG 46 rhLF 46 HORIZONS AMI trial 46 rxRNA 46 DATATRAK eClinical ™ 46 TrialNet 46 website www.rxipharma.com 46 JVRS 46 Acute MI 46 QLT Plug Delivery 45 PREVU x LT 45 PRESEPT 45 computed tomographic 45 PROactive 45 AND RECOMMENDATIONS 45 Screening Trial DMIST 45 borehole geophysical 45 Roughrider East 45 SIMPADICO 45 Phenotypic 45 geomorphological 45 CLARITY TIMI 45 potent suppressor 45 drillhole database 45 Urocortin 2 45 miRview mets 45 DIAGNOSTICS 45 intra abdominal abscess 45 geological geochemical geophysical 45 mean ± SEM 45 Vendor Profiles 45 REVIVE Diabetes 45 PresbyLens ® 45 FDG PET imaging 45 Phase III psoriasis 45 Perceptive Informatics 45 Phase IIA 45 GORE TAG Device 45 Fourier domain 45 deformational 45 PET SPECT 45 LifeShirt System 45 tolerability pharmacokinetics 45 vascular ultrasound 45 cerebrovascular adverse 45 Endarterectomy 45 Decompensated Heart Failure 45 Topics Covered Executive 45 BLOSSOM 45 IN PATIENTS WITH 45 HYVET 45 Histopathological 45 ray fluorescence 45 Magnetic Particle Imaging 45 dose escalation Phase 45 geological geotechnical 45 AvalonBay Communities Announces 45 prognostic variables 45 farletuzumab 45 Lung Injury 45 Genta Incorporated OTCBB GETA 45 Cathy.Hales @ htimes.com 45 endoscopic ultrasonography 45 putative biomarkers 45 CALGB 45 thorough QT 45 MERLIN TIMI 45 Confocal Laser 45 EXHIBITS AT 45 Urgent Intervention Triage 45 SF #v# 45 tumor subtypes 45 Adverse Childhood 45 Geochimica et Cosmochimica Acta 45 Roadmapping 45 Pharmacokinetic PK 45 MicroThermX 45 Anuri kimberlite 45 J Immunol 45 Data Extraction 45 ANNOUNCES FIRST QUARTER 45 Tres Juanes Norte 45 SYNTAX 45 GEMS TM 45 VICTOR E1 45 PLCO 45 HuMax TAC 45 COSTAR II 45 oral NKTR 45 REMINYL ® 45 gadolinium enhanced 45 Ouro Verde deposit 45 ASSAY RESULTS 45 bapineuzumab AAB 45 multicenter randomized controlled 45 Hepatotoxicity 45 Microwave Ablation System 45 Intervention Trial 45 PRNewswire FirstCall VirtualScopics 45 Evidence Therapeutic 45 azilsartan medoxomil 45 Tarceva TM 45 geologic interpretations 45 Emba Derho deposit 45 petrological 45 mineralogical studies 45 esophageal carcinoma 45 chromosome #p# [002] 45 RE LY trial 45 EUS FNA 45 longitudinal observational study 45 Riviere Dore 45 intracoronary 45 pharmacodynamic PK PD 45 Coronary artery bypass grafting 45 syngo R 45 ABCSG 45 PRNewswire FirstCall Genta Incorporated 45 Halozyme Ultrafast Insulin 45 peptidome 44 SUCCEED trial 44 dbGaP 44 TRITON TIMI 44 recurrent glioblastoma multiforme 44 neoadjuvant treatment 44 liver transaminases 44 Diamyd Medical Diamyd 44 ECG gated 44 clinicopathologic 44 Kahalalide F 44 Opportunity Assessment 44 SANGAMON 44 Phase Ib IIa 44 transesophageal echocardiography TEE 44 BROADEN 44 hydrothermal brecciation 44 CT Angiography 44 Multivariate 44 Vertebral Fracture 44 bortezomib Velcade 44 PharmaPros 44 Kaplan Meier analysis 44 periprocedural MI 44 ExAblate R 44 Postmarketing 44 BACKGROUND AND 44 Geochemical Survey 44 Phase #/#a clinical 44 Anticalin ® 44 COGENT 44 HuCAL antibodies 44 Silodosin 44 Vicor Technologies Announces 44 tramiprosate Alzhemed TM 44 SYMMETRY trial 44 transoral 44 DAVANAT R exhibits 44 flurpiridaz F 44 Sentinel lymph node 44 Airborne geophysics 44 circulating endothelial cells 44 ELCAP 44 SWOG 44 Roughrider Uranium Deposit 44 REGARDS 44 Clin Oncol 44 NICE SUGAR 44 Stenting Trial 44 Pre RELAX AHF 44 Radiographic 44 NCT# ClinicalTrials.gov 44 EM BS 44 storage semiconductor HB-LED/wireless 44 Electromagnetic EM 44 protein microarrays 44 HRCT 44 Mala Noche Footwall Zone 44 Confocal 44 fluorescein angiography 44 phase IIa 44 PHASE II 44 ILLUSTRATE 44 XPEL Announces 44 NEVO RES 44 ChromoCure 44 subanalysis 44 Raloxifene STAR 44 DIAGNOSTIC 44 Serrote Deposit 44 Breast Specific Gamma 44 susceptibility locus 44 EMPHASIS HF 44 dimensional visualization 44 fundus photography 44 SEISMIC 44 differential gene expression 44 Grouped Hockey 44 prospective observational cohort 44 gravity geophysical surveys 44 Affymetrix microarray technology 44 Evaluation WISE 44 Automated Breast Ultrasound 44 histopathologic findings 44 prospective randomized multicenter 44 IP induced polarization 44 Goldrich Mining Company 44 ENGAGE AF TIMI 44 ICAEL 44 KENOSHA AREA CONVENTION 44 Auxilium anticipates 44 metabonomics 44 Diabetes Complications 44 CADstream automates 44 Sirolimus eluting 44 Health Initiative Observational 44 CLL8 44 radiographic evaluation 44 Corporation Nasdaq PHRM 44 CryoPlasty 44 catechol O methyltransferase COMT 44 Phase Forward InForm 44 macromolecular structure 44 ENDEAVOR III 44 Patient Registry 44 Prostate Cancer Prevention 44 RE MODEL 44 HOLE NO 44 ASCO Abstract 44 Elan NanoCrystal 44 Multiethnic Study 44 comparative genomic 44 multicenter trials 44 fidaxomicin Phase 44 exome capture 44 lithogeochemical 44 AREDS 44 clinico pathological 44 genomewide 44 histopathological 44 tramiprosate 44 Ultrafast Insulin 44 endophenotypes 44 radioligand 44 Neuroepidemiology 44 Hyperparathyroidism 44 HRTEM 44 Forward Looking IVUS 44 Arch Intern Med 44 Phase 1a 44 T2 weighted MR 44 ENVISION 44 ACOMPLIA R 44 plasma lipoprotein 44 PINKSHEETS KKUR 44 biomarker identification 44 domain optical coherence 44 vidofludimus 44 preclinical pharmacology 44 neoadjuvant 44 multiplanar 44 geophysical interpretations 44 clinical pharmacology studies 44 MOLECULAR 44 CGEMS 43 antiretroviral naïve 43 Multivariate logistic regression 43 TSX VENTURE BTR FRANKFURT 43 Nordic ACTI 43 TRUS 43 extracranial 43 Beyondie Project 43 LIFE Biosystems 43 Pharmacokinetic 43 YOUR E MAIL 43 BioImage Study 43 risk stratification 43 genomic microarray 43 Western Airborne Contaminants 43 transvaginal sonography 43 liposomal formulation 43 EXPLORATION PROGRAM 43 NOX E# 43 atherothrombotic 43 SWiTCH 43 NCCTG 43 asthma immunotherapeutic 43 Optovue 43 PRNewswire FirstCall QMed 43 PROBLEMS WITH THE 43 MR imaging 43 REVIVE TA 43 BUSINESS TRAVEL CONSULTANT 43 HOLD FOR RELEASE 43 PDE# inhibitors 43 Korkan target 43 endothelial progenitor cell 43 histopathologic diagnosis 43 neuropathologic 43 rhMBL 43 GAMMAGARD 43 pathogenetic mechanisms 43 TQT 43 Plicera 43 spiral computed tomography 43 Idenix anticipates 43 geophysics prospecting 43 optical biosensors 43 Factor VIIa 43 Valhi Reports 43 biosimulation 43 Mantel Haenszel 43 retrospective cohort 43 TOFUTTI Announces 43 EDEMA3 43 SLAM Exploration Ltd. 43 SPACECRAFT 43 Senior Geochemist 43 Multicenter Automatic Defibrillator Implantation 43 HSCR 43 COPERNICUS 43 Annexin V 43 stylus profilers 43 OZURDEX 43 GRAVITAS trial 43 Dialysis Outcomes 43 Thorough QT TQT 43 Non Alcoholic Steatohepatitis 43 Cervical Cytology 43 Trial NLST 43 evaluating Prochymal 43 Renal Cell Carcinoma RCC 43 PHX# 43 StockPickReport.Com ranks stocks 43 Atherosclerosis MESA 43 validating biomarkers 43 Cytogenetic 43 InForm ITM 43 Rigorous scientific 43 abdominal computed tomography 43 HEALTH CALENDAR 43 TLR antagonists 43 airborne geophysical surveying 43 cortical stimulation 43 2D electrophoresis gels 43 prelicensure 43 vivo glucose 43 natural orifice transluminal 43 FEATURED AT 43 AOQ MT 43 HPTN 43 Computational biology 43 MI DIARY Top 43 Enzyme Replacement Therapy 43 colonography 43 #rd Annual CTRC 43 Phase 2b randomized 43 drilling wireline logs 43 Beta catenin pathway 43 PARTNER Trial 43 Modifiable 43 Datasets 43 eSource 43 exponential regression 43 electrophysiological potentials 43 COU AA 43 morphometric 43 Outcome Measures 43 multidetector CT 43 cardiac magnetic resonance 43 metachronous 43 MONMOUTH UNIVERSITY 43 Anceta 43 DASISION 43 OR BEFORE 43 adjuvant endocrine therapy 43 XTEN 43 PRT# 43 Optimised Feasibility Study 43 Integrium 43 Adult Cardiac Surgery 43 mixed hyperlipidemia 43 Phenotype 43 etiologic 43 Computed tomography 43 Women Ischemia Syndrome 43 BioNumerik 43 Sonographic 43 Megatem 43 NP2 Enkephalin 43 Registry NOPR 43 demonstrated antitumor activity 43 excavator trenching 43 stream sediment geochemical 43 FOR BREAST CANCER 43 Preliminary Assessment Report 43 prospective nonrandomized 43 pixel RGB 43 AVERROES 43 inferential statistics 43 frac horizontal 43 underground longwall mining 43 CALM Shoulder Screen 43 Wisconsin Sleep Cohort 43 PROPEL trial 43 T1 weighted images 43 Complications Trial 43 LDRA Testbed 43 Statistically Significant Improvement 43 eClinical Solutions 43 Talotrexin 43 airborne radiometric magnetic 43 transurethral 43 Cloretazine 43 WHEL 43 Bowel Project NSABP 43 oncologic outcomes 43 uricase 43 pharmacokinetic pharmacodynamic 43 SORT OUT 43 Vasogen Celacade 43 PremierWest Bancorp Announces 43 ConclusionThis 43 F FDG PET 43 Primary endpoints 43 PAYMENT PLEASE PAY WITHIN 43 geochemical assay 43 BUT SINCE 43 Dr. Gabriel Lasala 43 CardioFit 42 colleague Sana Inoue 42 surface geochemical sampling 42 Radiation Therapy Oncology 42 Alpha Tocopherol Beta Carotene 42 USGI Medical 42 NTQ MT 42 Numoda 42 IL 6R 42 Hemospan 42 ABSORB trial 42 NEWS RELEASES 42 Drug Eluting Balloon 42 COMMENCES 42 OTCBB RDIAF announces 42 Certej Project 42 Reanalysis 42 Preoperative 42 empirically validated 42 IIa trials 42 ground truthing 42 APEX AMI 42 AFRRI 42 Radius Studio 42 slice computed tomography 42 EVENTS IN 42 Induced polarization IP 42 TASKi2 42 angiography CCTA 42 Soliris eculizumab 42 PITX2 methylation 42 VerifyNow P#Y# 42 analysis FEA 42 Repeatable Battery 42 Bayesian statistical 42 RenalGuard System TM 42 SPIRIT III 42 initiate Phase 1b 42 Inc. Nasdaq ALSE 42 Celator 42 Microdiamond 42 reconnaissance mapping 42 CT Colonography Trial 42 Vilazodone 42 ABSSSI 42 Glufosfamide 42 geophysical geological 42 Airborne geophysical surveys 42 MADIT II 42 amnestic mild cognitive impairment 42 vivo molecular imaging 42 infill sampling 42 liver resection 42 ug dose 42 BRIEFING ASIA 42 Larry Cornman physicist 42 MatchMetrix 42 Serological 42 MERIT ES 42 RIO Lipids 42 intensive lipid lowering 42 Cites Positive 42 Society CTOS 42 QTinno 42 choroidal neovascularization 42 intestinal permeability 42 THERAPEUTICS 42 Group RTOG 42 hydrothermal alteration zones 42 ARDIS 42 Improved Second Quarter 42 Itigi Manyoni Uranium 42 fidaxomicin Phase 3 42 intratumoural 42 AirBoss Announces 42 ENDEAVOR clinical 42 LAUNCHES IN 42 NESARC 42 dose proportionality 42 LISTED IN 42 TSX VENTURE KYM 42 SAXS 42 HF ACTION 42 Randomized trials 42 Drill Hole Locations 42 Heart Failure Trial 42 OYO Geospace Reports 42 TECHNOLOGIST 42 Quantitative RT PCR 42 TNM staging 42 ECASS 42 Stratus OCT 42 Quantec Geoscience Limited 42 FDG PET CT 42 Microprobe 42 Zemiva 42 MORE MTQ 42 Snowfall Impact 42 biomarker assays 42 papillary renal cell carcinoma 42 ePharmaSolutions 42 Vernakalant 42 Cellvizio 42 #m@#.#g t [006] 42 Acute Coronary Syndromes 42 KRAS mutation 42 malignant ovarian 42 DEVELOPMENT PROJECT 42 electron tomography 42 anomalous radiometric 42 hemagglutination inhibition HAI 42 MMI soil geochemical 42 GRRL Tech Women 42 cardiac computed tomography 42 phakic 42 skeletal sarcomere activators 42 hyper spectral 42 Transesophageal 42 StockGuru.com Announces Profile 42 3D Induced Polarization 42 GEOCommand 42 THERAPY AND 42 CONDOR 42 TOCCATA 42 clinically localized prostate 42 TruDefender FT 42 PKC# 42 ORAL Sync 42 Preliminary Assessment Study 42 FDG PET 42 INTERNATIONAL CONVENTION 42 Microarray analysis 42 obscure gastrointestinal bleeding 42 selective adenosine 42 gene rearrangements 42 p# Shc 42 Archived webcasts 42 paleoenvironmental 42 GROWS IN 42 airborne magnetics 42 GlobalData viewpoints cover 42 microbiology immunology epidemiology 42 retrospectively analyzed 42 Phase Ia 42 immuno therapeutic 42 Elekta Synergy R 42 BioMarck 42 Diamondback #deg 42 vitro ADMET 42 MSCRAMM R 42 Ameris Bancorp Reports 42 ACCEDE 42 HuMax 42 Ground penetrating radar 42 imaging MRI 42 GENASIS clinical 42 DEcIDE 42 CABERNET 42 RG# ITMN 42 HEARING IN 42 Albuferon Phase 42 Konkera 42 ON FEB 42 #:# scale 42 Trial PCPT 42 Coronary angioplasty 42 MEGATEM 42 Contrast Enhanced 42 myoblast 42 bioabsorbable stent 42 histologic findings 42 petrographic 42 petrographic studies 42 Trans Lux Reports 42 INTEGRAL 42 TrialStat 42 OPENS AT 42 AND NORTHWEST 42 bioinformatic analysis 42 ProstaScint 42 IP Resistivity survey 42 CSAMT MT 42 McFaulds Lake Property 42 MEDICAL CENTRE 42 Crystalens AO 42 NewsRx.com 42 Heap leach 42 Diaries Diaries 42 PharMetrics 42 Oncotype DX TM 41 SuperMedia specializes 41 AVN# Phase 41 Techni lab 41 Cornea Donor Study 41 LOW PRESSURE WILL 41 INT subsystems 41 sodium thiosulfate STS 41 Maven Semantic http:/www.mavensemantic.com announBruising Brandon 41 BAILEY CIRCUS 41 element geochemical 41 dravite 41 VFEND 41 Crowflight Announces 41 Stratus OCT TM 41 GPNMB expression 41 NCCTG N# 41 EXPLOSION IN 41 PillCam ESO 41 Taping Results SPOILERS 41 echocardiographic 41 prostate carcinogenesis 41 HMQ MT 41 Nord Trøndelag Health 41 Prefeasibility 41 website www.orvana.com 41 inversion modeling 41 Univariate 41 pharmacodynamic endpoints 41 RESOURCES INC. TSX VENTURE 41 RESCHEDULED FOR 41 Inclinix 41 MIST Therapy 41 Therma Med Inc. 41 genotypic 41 Surfaxin LS 41 Phase III confirmatory 41 subsurface geology 41 photodynamic therapy PDT 41 thoracoscopic lobectomy 41 Shiranish formation 41 IPAH 41 HPA Consultants 41 While Ambrilia anticipates 41 EMBARGOED UNTIL 41 AOQ 41 recombinant factor VIIa 41 coincident geochemical 41 Comorbidity 41 conducted retrospective cohort 41 transesophageal echocardiography 41 FRANKFURT E2G 41 SHOPPING MALL 41 Follow LiveScience 41 myocardial revascularization 41 clinicopathological 41 coronary revascularisation 41 Resource Calculation 41 prognostic significance 41 CORPORATION ANNOUNCES 41 NLTX 41 IntroductionThe 41 Biomerk Tumorgrafts 41 NTQ 41 YOUR WINNING BID 41 GeoVax HIV AIDS 41 HGPIN 41 Post hoc 41 borehole electromagnetic 41 CIMZIA ™ 41 renal tumors 41 physico chemical 41 #th Annual Interscience 41 Ongoing metallurgical 41 HONG KONG NEWSPAPER HIGHLIGHTS 41 intravascular imaging 41 ZOLL resuscitation product 41 Represa Zone 41 Promedior 41 geological mapping trenching 41 GHIS 41 #-# Resource Estimate 41 prnewswire More 41 Quebrada Verde